All the news Showing 10 of 19 articles from: NAFLDGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Novel Thyroid Beta Receptor Agonist Cut LDL-C in NAFLD Patients MedPage Today Gastroenterology / 14 November 2018 People with fatty liver disease are at greater risk for multiple cancers Liz Highleyman / 12 November 2018 People with non-alcoholic fatty liver disease (NAFLD) were found to have higher rates of cancer, with the greatest increase observed for gastrointestinal cancers, according to findings presented yesterday at the 2018 AASLD Liver ... HIV infection is a risk factor for liver fat accumulation Liz Highleyman / 13 August 2018 People living with HIV are about twice as likely to develop steatosis, or fat accumulation in the liver, even if they don't have hepatitis B or C co-infection, according to a study presented at ... Diet Heavy in Meat Boosts NAFLD Risk MedPage Today Gastroenterology / 07 August 2018 Mixed results for experimental therapies for NASH Liz Highleyman / 22 June 2018 The recent International Liver Congress in Paris featured several presentations on investigational therapies for fatty liver disease. Drugs with a range of different mechanisms – including the thyroid hormone receptor agonist MGL-3196, ... Costs Balloon after Cirrhosis Diagnosis for NAFLD/NASH MedPage Today Gastroenterology / 17 April 2018 Cenicriviroc treatment improves liver fibrosis in people with NASH Liz Highleyman / 13 April 2018 Cenicriviroc, a drug that blocks both CCR5 and CCR2 receptors on immune cells, continued to show an anti-fibrotic effect in people with non-alcoholic steatohepatitis (NASH) after two years of follow-up, according to a ... Mediterranean diet reduces liver fat, risk for NAFLD Healio Hepatology / 03 April 2018 Alcohol consumption and metabolic factors act together to increase the risk of severe liver disease Eurekalert Medicine & Health / 22 November 2017 New EACS treatment guidelines Keith Alcorn / 31 October 2017 Everyone with HIV and hepatitis C virus (HCV) co-infection should receive direct-acting antiviral treatment for hepatitis C and should receive the same treatment for hepatitis C as people with hepatitis C monoinfection, ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds